Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-29

Clinical Trial Update: Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluating hypofractionated proton radiation therapy for low- and intermediate-risk prostate cancer has been reported. The trial was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Florida | Conditions: Prostate Cancer | NA | Status: COMPLETED